Evidence map›Paper›PMID 35807219›Full record

ReviewMolecules (Basel, Switzerland)2022

Recent Progress in Azopyridine-Containing Supramolecular Assembly: From Photoresponsive Liquid Crystals to Light-Driven Devices.

Hao Ren, Peng Yang, Haifeng Yu

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hao RenKey Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, China.
Peng YangKey Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, China.
Haifeng YuInstitute of New Structural Materials, School of Material Science and Engineering, Peking University, Beijing 100871, China.ORCID 0000-0003-0398-5055

Funding

National Natural Science Foundation of China 21905166, 21875132,51921002, 92156011Natural Science Basic Research Program of Shaanxi 2020JQ-406
6 · The paper itself

Abstract

Azobenzene derivatives have become one of the most famous photoresponsive chromophores in the past few decades for their reversible molecular switches upon the irradiation of actinic light. To meet the ever-increasing requirements for applications in materials science, biomedicine, and light-driven devices, it is usually necessary to adjust their photochemical property from the molecular level by changing the substituents on the benzene rings of azobenzene groups. Among the diverse azobenzene derivatives, azopyridine combines the photoresponsive feature of azobenzene groups and the supramolecular function of pyridyl moieties in one molecule. This unique feature provides pH-responsiveness and hydrogen/halogen/coordination binding sites in the same chromophore, paving a new way to prepare multi-functional responsive materials through non-covalent interactions and reversible chemical reactions. This review summarizes the photochemical and photophysical properties of azopyridine derivatives in supramolecular states (e.g., hydrogen/halogen bonding, coordination interactions, and quaternization reactions) and illustrates their applications from photoresponsive liquid crystals to light-driven devices. We hope this review can highlight azopyridine as one more versatile candidate molecule for designing novel photoresponsive materials towards light-driven applications.

Indexed as

Liquid CrystalsHalogensHydrogenHydrogen BondingHalogensHydrogenazopyridine-based materialsliquid crystalphotoresponsive materialsupramolecular assembly

Identifiers

PMID35807219
PMCPMC9268027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.